Though lumps are not all malignant, or cancerous, early discovery is always an advantage.
尽管“块煤”并不一定是恶性或癌性的,但尽早发现总归是件好事。
Advexin, devised by Introgen, an American company, is aimed at combating head and neck cancer; and London-based Ark Therapeutics’ Cerepro targets malignant glioma, a fatal brain tumour.
由一家美国公司Introgen 设计的Advexin目标在于攻克头颈部癌症;位于伦敦的Ark Therapeutics生产出的Cerepro将目标对准了恶性胶质瘤,一种致死性的脑肿瘤。
Of those 60,000 deaths, an estimated 48,000 are caused by malignant melanomas, and 12,000 by skin carcinomas.
在这6万死亡中,估计有48000是由恶性黑素瘤造成的,12000是由皮肤癌造成的。
应用推荐